PHCbi

CASE STUDIES

Ehime University Graduate School of Medicine(Ehime)

Print

An innovative approach to T cell research with the Live Cell Metabolic Analyzer

Professor Masakatsu Yamashita of the Departments of Immunology and of Infections and Host Defenses at Ehime University Graduate School of Medicine has been working on research into T cell differentiation and functional regulation, which he hopes will lead to the development of anti-cancer immunotherapies and vaccines, as well as new treatment strategies for patients with allergies or autoimmune diseases.

Professor Yamashita has been conducting research for many years with a specific focus on how T cell functions are controlled by metabolism and epigenetics. We asked Professor Yamashita how he is using the PHC LiCellMo live cell metabolic analyzer in his T cell metabolism research.

Professor Yamashita, please tell us about your research theme.

We are looking at immunology, specifically, how the functions of T cells are controlled by metabolism and epigenetics.

Naive T cells undergo clonal expansion upon antigen stimulation, during which metabolic and epigenetic reprogramming occurs, enabling their differentiation into various types of T cells.

I started my T cell research when I was working for a pharmaceutical company some time ago. I became hooked on the fascinating world of T cells and their remarkable development, and I am still working on it today. Over the last 10 years I have been looking in particular at how T cell metabolites regulate a great many epigenetic control factors to try and understand the relationship between metabolism and epigenetics.

What prompted you to start using the LiCellMo?

The biggest problem in my experiments so far has been picking the right time to measure metabolites. When I heard that the LiCellMo can chart the glucose consumption rate and lactate production, I was keen to use it to determine the right time for taking measurements when using analytical devices, so this was why I started using it.

I also previously worked on research using mice in which glycolysis enzymes were knocked out, and I found that mice without these enzymes were unable to sustain either T cell differentiation or signal transduction. This finding made me realize that glycolysis needs to be observed very carefully.

The convenience of regular cultures -a useful tool for both beginners
and experienced researchers in metabolic analysis

What were your impressions after using the LiCellMo?

With T cell differentiation, using the LiCellMo has made it possible to compare metabolic changes and reactions at each of the specific timepoints when you make CD4-positive T cells differentiate into Th1 cells, Th2 cells, Th17 cells, and regulatory T cells, or when you make CD8-positive T cells differentiate into cytotoxic T cells.

I felt that, for beginners in the field, the LiCellMo is an intuitive tool for understanding metabolism, and it is likely to be useful even for researchers who are unfamiliar with metabolic analyses. At the same time, for researchers who are already working on metabolic analyses, it is an attractive option because it can be used as a powerful auxiliary tool for verifying predicted behaviors.

My impression is that it is extremely user-friendly and has a simple design, so that even first-time users can come to grips with it easily. Once you start, the device takes care of the measurements automatically, so using it is as straightforward as doing a regular culture. You don’t need any special plates, so the preparation is simple.

By observing changes in the consumption rate, you can grasp overall trends

Using the LiCellMo has made it possible to determine whether the glucose consumption rate rises sharply or increases gradually over time. This is the major benefit of chronological measurements, and it is extremely useful to be able to see overall changes in detail.

We used to measure metabolic states at 24 hours and 48 hours, which were specific timepoints determined through experience, but we had no way of knowing the reaction speed between these points. For example, you may get the same results after 24 hours, but by using the LiCellMo, you can now tell how the changes in metabolic activation progress over this period with differences in culture conditions.

Say you go from Ehime to Tokyo, the end result is the same however you travel—you arrive in Tokyo. However, we can now observe you en route to see whether you went by airplane or whether you took a slower trip on the bullet train.

In an actual situation, the end result of a culture after 48 hours looks the same whether or not you add a particular cytokine, but we found out that the progress and speed during the intervening period are different. The ability to acquire this sort of detailed information is enormously valuable.

Chronological measurement has made it possible
to observe changes in differentiation and activation of T cells

What do you feel are the main strengths of the LiCellMo?

I think the biggest advantage has to be the ability to make chronological measurements. Particularly in the field of the immune system, with the differentiation or activation of T cells, B cells, and macrophages, there are precise triggers that recognize antigens, which is the starting point from which dramatic changes in metabolism occur. I think this makes the LiCellMo particularly suitable for work in the field of immunology.

We have also discovered that, after T cells are stimulated by an antigen and their glycolysis is dramatically activated, a cytokine called IL-2 is needed to sustain this glycolysis. Processes like this can be confirmed in vitro using the LiCellMo. In fact, we have confirmed that metabolism can be observed not only in T cells, but also in B cells.

We have also found that, when differentiation of CD4-positive T cells into helper T cell subsets, such as Th1 or Th2 cells, is induced in vitro, the level of activation of glycolysis and the time for which it is sustained vary greatly depending on the conditions. This is also something that was only discovered when observations were made over time. Information such as, for example, the level at which glycolysis activation is sustained or how the consumption rate changes over time can only be obtained through chronological measurements.

Also, if you have a decrease in lactate, which is a downstream molecule in glycolysis, a tool like the LiCellMo is absolutely invaluable for determining whether this is due to changes in the consumption rate or whether some other factors are involved.

Using the LiCellMo allows us to measure over time whether glucose and lactate metabolism are being held back, or whether they are decreasing because large amounts have been used.

This is the big advantage of the LiCellMo - the chronological measurements show us things that we couldn’t grasp before from measurements that were just single snapshots.

Functionality that allows measurement to be finished whenever you want, and a 24-well plate that ensures you have enough cells for direct reuse in other analyses

The big advantage of the LiCellMo is that, if at any time during measurement you want to carry out more detailed observations of the cells, you have the flexibility to finish measuring and collect the cells for transfer to another measuring device for more detailed analysis. An important feature of the LiCellMo is that it uses 24-well plates, which ensures that you have enough cells for use in other analyses, such as flow cytometry or Western blotting.

For example, while we measure the glucose consumption rate, we collect cells every 48 hours and use them for analysis in separate devices. We also observe changes in intracellular markers when glycolysis is activated, so that we can verify in detail the relationships between metabolism and molecular markers. In this sense, the LiCellMo plays a very important role in complementing the fragmented information that is all that other analysis devices can provide.

How do you see the prospects for future research?

I would like to use the LiCellMo to screen for the effects of disease-specific metabolites and proteins on cell metabolism, particularly glycolysis.

For example, I envision the LiCellMo being useful in observing activation of glycolysis accompanying diseases, which could be used not just for discovering disease markers, but also for screening substances potentially leading to drug development.


In this interview, Professor Yamashita discussed his reasons for adopting the LiCellMo, and he shared some specific insights into how this device is contributing to his research into T cells. Looking to the future, PHC’s LiCellMo is set to become a game-changer in the field of immunological research, with applications that include screening pharmaceuticals for drug discovery.